Hematopoietic Stem Cell Mobilization With Plerixafor in Sickle Cell Disease

Haematologica - Italy
doi 10.3324/haematol.2018.190876
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Plerixafor for Stem Cell Mobilization in Allogeneic Stem Cell Donors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Hematopoietic Stem Cell Mobilization

Haematologica
Hematology
2008English

Single-Agent Plerixafor Mobilization to Collect Autologous Stem Cells for Use in Gene Therapy for Severe Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Efficacy of Late Hematopoietic Stem Cell Mobilization 35-40 Hours After Administration of Plerixafor

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Shared Decision Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: State of the Science

European Journal of Haematology
MedicineHematology
2014English

Plerixafor Overcomes the Adverse Effect of Diabetes on Hematopoietic Progenitor Cell Mobilization

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology
Hematology
2016English

Autologous Stem Cell Mobilization in AL Amyloidosis With Plerixafor and G-Csf: Update of a Single Center Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy